143 related articles for article (PubMed ID: 9352120)
21. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
Richards CA; Short SA; Thorgeirsson SS; Huber BE
Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
[TBL] [Abstract][Full Text] [Related]
23. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
24. Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice.
Guerrero S; Figueras A; Casanova I; Farré L; Lloveras B; Capellà G; Trias M; Mangues R
FASEB J; 2002 Oct; 16(12):1642-4. PubMed ID: 12207005
[TBL] [Abstract][Full Text] [Related]
25. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas.
Chang KW; Lin SC; Koos S; Pather K; Solt D
Carcinogenesis; 1996 Mar; 17(3):595-600. PubMed ID: 8631150
[TBL] [Abstract][Full Text] [Related]
26. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
27. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
28. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
[TBL] [Abstract][Full Text] [Related]
29. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
30. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
[TBL] [Abstract][Full Text] [Related]
31. T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.
Senger DR; Perruzzi CA; Ali IU
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5107-11. PubMed ID: 3293049
[TBL] [Abstract][Full Text] [Related]
32. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.
Popp S; Waltering S; Herbst C; Moll I; Boukamp P
Int J Cancer; 2002 May; 99(3):352-60. PubMed ID: 11992403
[TBL] [Abstract][Full Text] [Related]
33. p53 mutations in bladder carcinoma cell lines.
Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic potential of BRAF versus RAS.
Benjamin CL; Ananthaswamy HN
Cancer Lett; 2008 Mar; 261(2):137-46. PubMed ID: 18280030
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations.
Hollstein MC; Peri L; Mandard AM; Welsh JA; Montesano R; Metcalf RA; Bak M; Harris CC
Cancer Res; 1991 Aug; 51(15):4102-6. PubMed ID: 1855226
[TBL] [Abstract][Full Text] [Related]
37. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
38. Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.
Sun Y; Nakamura K; Wendel E; Colburn N
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2827-31. PubMed ID: 8464896
[TBL] [Abstract][Full Text] [Related]
39. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia.
Yeargin J; Cheng J; Haas M
Leukemia; 1992; 6 Suppl 3():85S-91S. PubMed ID: 1602834
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines.
Min BM; Baek JH; Shin KH; Gujuluva CN; Cherrick HM; Park NH
Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):338-45. PubMed ID: 7703804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
